As the comment period closes on a Centers for Medicare & Medicaid Services (CMS) proposal to test new payment strategies for Medicare Part B prescription drugs, 25 organizations representing people with Medicare, health plans, and health care professionals are voicing their strong support for the model. The proposal presents an opportunity to improve health care quality and value for people with Medicare and also support providers in delivering the right care at the right time.

Community Catalyst recently launched an initiative, the Center for Consumer Engagement in Health Innovation (the Center) to “make our health

This week, AARP released the results of a survey that examined consumers’ prescription drug use and opinions regarding cost. The survey captured common struggles consumers face with the cost of prescription drugs and consumer views on legal strategies to reduce prescription drug costs.

Do you or a loved one have Medicare and Medicaid and long term care needs? If so, you may have recently experienced a change to the way you receive your coverage. The Medicare Rights Center’s Coalition to Protect the Rights of New York’s Dually Eligible (CPRNYDE) tracks changes New Yorkers with Medicare and Medicaid and long-term care experience, and we would like to hear your story.

This week the Centers for Medicare & Medicaid Services (CMS) Office of Minority Health released data about the quality of care provided by Medicare Advantage plans to enrollees of various racial or ethnic groups, marking the first time CMS made quality information stratified by race and ethnicity publicly available.

This week, President Obama signed into law the reauthorization of the Older Americans Act (OAA), which expired in 2011. The OAA was originally signed into law by President Lyndon Johnson in July 1965, and for more than 50 years, it has provided the nation with programs that allow millions of older Americans to continue living and thriving in the communities of their choice for as long as possible.

Earlier this week, the Medicare Rights Center participated in a panel discussion at a public forum convened by the Pew Charitable Trusts on a proposal by the Centers for Medicare & Medicaid Services (CMS) to test new ways to pay for Medicare Part B prescription drugs. Other panelists included experts on prescription drugs, pharmaceutical makers, and clinical oncologists. The discussion focused on the panelists’ views of the potential merits and downsides of the CMS proposal.

Last week, the Centers for Medicare & Medicaid Services (CMS) published the 2017 Medicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and Final Call Letter (2017 Final Notice and Call Letter). In March, Medicare Rights submitted comments on the draft version of the call letter supporting of many of the proposed changes, which seek to improve the accuracy of payment structures and strengthen plan accountability. The 2017 Call Letter finalizes most of the proposals included in the draft letter, with some moderate changes.

This week, Medicare Rights submitted comments requesting that the Centers for Medicare & Medicaid Services (CMS) withdraw a proposal to explore requiring prior authorization for home health care services. These services include home-based skilled nursing and therapy care for people with Medicare who are homebound, meaning they are unable to leave their home without difficulty.

Recently, the Centers for Medicare & Medicaid Services (CMS) Innovation Center proposed a demonstration to test new strategies to pay for medications that are covered under Part B. Most prescription medications are covered under Medicare Part D, but some (mostly those administered by a doctor) are paid for under the outpatient Part B benefit.

Common Part B prescription drugs treat cancer, macular degeneration, anemia, and arthritis. Part B medications tend to be very expensive—in 2013, Medicare and its beneficiaries spent $19 billion on Part B prescriptions.